Insights & Updates in Treatment of Iron deficiency Anemia
This series consists of three CME activities to launch beginning November 2017. As each activity becomes available, the links below will direct learners to the activity details and content.
Iron deficiency anemia (IDA) is associated with myriad disease-related causes in the United States, making it a widespread problem leading to significant morbidity and occasional mortality. Further, it is often easily treatable via either oral or IV iron therapy. Although IDA is a manageable disease with appropriate treatment, widespread undertreatment/underdiagnosis of this disease is apparent across patient demographics. Clinicians require up-to-date knowledge of anemia assessment, diagnosis and management of IDA to reduce its burden and improve clinical outcomes.
IDA in Inflammatory Bowel Disease: Pathology, Treatment Options, and the Risks of Underdiagnosis
Clinical Commentary
This activity will discuss the unique clinical relationship between inflammatory bowel disease (IBD) and iron deficiency anemia (IDA), including the role IBD pathology plays in blocking optimal iron absorption. Many IBD patients contend with multiple challenges and comorbidities that all can directly or indirectly lead to IDA and subsequent poor outcomes. A leading gastroenterologist will discuss IDA-related diagnostic challenges, treatment options, and management protocols for IBD patients.
Faculty: Paul Feuerstadt, MD FACG
Release Date:
Expiration Date: November 30, 2018
CME/CE is no longer available for this activity
IDA Pathology, Etiology, and the Role of Hepcidin Across At-Risk Patient Populations
Clinical Commentary
Iron-deficiency anemia (IDA) is a widespread condition affecting multiple patient populations, which can range from elderly patients and women of childbearing age to cancer patients, chronic kidney disease patients, and persons with gastroenterological conditions such as IBD, among others. IDA also affects populations not traditionally screened for iron deficiency, such as those with certain cardiovascular conditions such as congestive heart failure and cardiomyopathy. In this activity, a leading hematologist will discuss the pathology of IDA in multiple clinical patient subsets, as well as how hepcidin, a peptide hormone, regulates iron in the body in both normal human physiology and in multiple disease states.
Faculty: Ralph V. Boccia, MD
Release Date:
Expiration Date: December 08, 2018
CME/CE is no longer available for this activity
IDA in Gastroenterology Practice: Pathology, Differential Diagnostics, and Current Optimal Treatment Approaches
CME Touchpoint
Iron deficiency anemia (IDA) is encountered frequently in gastroenterology practice. Multiple GI disease states can contribute to the development of IDA, including IBD, celiac disease, liver disorders, prior bariatric surgery, angiodysplasia, diverticular disease, GI cancers, and other conditions that contribute to chronic GI bleeding, iron malabsorption, and/or inflammation. A leading gastroenterologist will discuss the importance of differential diagnosis in determining both direct and indirect causes of IDA frequently seen in gastroenterology practice, as well as appropriate therapeutic options and treatment protocols for various patient subsets.
Faculty: Paul Feuerstadt, MD, FACG
Release Date:
Expiration Date: December 29, 2018
CME/CE is no longer available for this activity
